s M-FLU | Reducing Transmission of Influenza by Facemasks
M-Flu | Reducing Transmission of Influenza by Facemasks
 
M-Flu News
News

References

  • (1) World Health Organization. Removing Obstacles to Healthy Development. 1999.
  • (2) World Health Organization. Influenza. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed July 09, 2007.
  • (3) Centers for Disease Control. Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States--Early, Targeted, Layered Use of Nonpharmaceutical Interventions. 2007; Available at: http://www.pandemicflu.gov/. Accessed 08-17-07, 2007.
  • (4) National Foundation for Infectious Diseases. Facts about Influenza for Adults. August 2006.
  • (5) Goldrick BA, Goetz AM. Pandemic influenza: what infection control professionals should know. Am.J.Infect.Control, 2007, 35(1): 7-13.
  • (6) Infectious Diseases Society of America (IDSA). Pandemic Influenza. Available at: http://www.cidrap.umn.edu/idsa/influenza/panflu/biofacts/panflu.html. Accessed July 10, 2007.
  • (7) Centers for Disease Control. Clinical Signs and Symptoms of Influenza. Available at: http://www.cdc.gov/flu/professionals/acip/clinical.htm Accessed October 12, 2007.
  • (8) Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, Cetron MS. Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic. JAMA. 2007; 298(6):644-654.
  • (9) Treanor JJ, Campbell JD, Zangwill KM, Rowe T and Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006; 354:1343-51.
  • (10) Ward P, Small I, Smith J, Suter P and Dutkowski R. Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic. JAC. 2005; 55:S5-21.
  • (11) Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM and Kerr C. Zanamivir prophylaxis: An effective strategy for the prevention of influenza types A and B within households. J Infect Dis. 2002; 186:1582-8.
  • (12) World Health Organization (WHO) Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg. Infect. Dis. 2006; 12:88-94.
Citizenship & Health As global citizens, we all have a responsibility to protect and maintain public health. Participants in the M-FLU Study are responding to the call for responsible global citizenship by contributing to research that may ultimately help guide the development of national policies for pandemic preparedness. M-FLU Study participants work to make the US and the world a safer, healthier place for us all.

> Make an impact - enroll in the study!